PureTech Health plc PTCHF
1.56 USD 0.00 (+0.00%)
At closeNov 4, 2026, 4:00 PM EST
1.56 Day range 1.56
1.45 52-week range 1.92
- YTD
- -8.77%
- 1 year
- -7.14%
- Market cap
- 382.48M
- YTD return
- -8.77%
- 1-year return
- -7.14%
- Volume
- 8.85K
- Avg volume
- 1.06K
- Open
- 1.56
- Previous close
- 1.56
- Day's range
- 1.56 – 1.56
- 52-week range
- 1.45 – 1.92
2Y -0.43 (-21.61%)
Financials — quick view
PTCHF Revenue — quarterly 5.73M
PTCHF Net income — quarterly 73.00K
PTCHF EPS — quarterly 0.02
News
PureTech Founded Entity Seaport Therapeutics Presents Additional Pharmacokinetic Data from Phase 1 Clinical Trial of GlyphAgo™ at the 39th European College of Neuropsychopharmacology (ECNP) Congress 
PureTech Health gets Panmure Liberum ‘buy' on value and cash returns 
PureTech Health: Results of Annual General Meeting 
PureTech Health shares boosted as investee Seaport Therapeutics prices Nasdaq IPO 
PureTech Health shares boosted as investee Seaport Therapeutics prices Nasdaq IPO 
PureTech Health plc (PRTC) Q4 2025 Earnings Call Transcript 
Short Interest in PureTech Health plc (OTCMKTS:PTCHF) Expands By 69.4% 
Cavendish sees Poolbeg’s POLB 001 gaining strategic importance as CRS research expands 
Greengage plans AQSE float with bold Bitcoin-backed lending strategy 
Puretech gains after FDA meeting post-Phase II trial
Your note
Sign in to keep a note on PTCHF — it syncs with the Stock Master app.